Interestingly, we recently found that expression of DYRK1A is associated with bad prognosis and poor clinical outcome in colorectal cancer patients, strongly suggesting a role for this kinase in colon cancer formation and/or progression21. Here, DYRK1A is linked to malignant colon neoplasm.